Decoy Therapeutics, Inc. (DCOY)

2.69 -0.19 (-6.60%) USD  |  NASDAQ  |  Sep 04, 16:00
2.74 +0.05 (+1.86%) After-Hours: 20:00
More

Decoy Therapeutics SG&A Expense (TTM) : 4.096M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for DCOY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 4.096M
March 31, 2026 3.619M
December 31, 2025 3.728M
September 30, 2025 4.639M
June 30, 2025 4.675M
March 31, 2025 5.079M
December 31, 2024 4.964M
September 30, 2024 4.562M
June 30, 2024 5.188M
March 31, 2024 5.555M
December 31, 2023 5.721M
September 30, 2023 6.603M
June 30, 2023 6.939M
March 31, 2023 7.156M
December 31, 2022 6.910M
September 30, 2022 6.848M
June 30, 2022 6.608M
December 31, 2021 6.105M
September 30, 2021 5.868M
June 30, 2021 5.470M
March 31, 2021 5.580M
December 31, 2020 6.106M
September 30, 2020 6.654M
June 30, 2020 8.815M
Date Value
March 31, 2020 8.082M
December 31, 2019 7.711M
September 30, 2019 7.205M
June 30, 2019 4.140M
March 31, 2019 6.167M
December 31, 2018 8.376M
September 30, 2018 11.10M
June 30, 2018 15.61M
March 31, 2018 17.61M
December 31, 2017 18.50M
September 30, 2017 18.44M
June 30, 2017 18.95M
March 31, 2017 19.34M
December 31, 2016 19.86M
September 30, 2016 20.56M
June 30, 2016 19.83M
March 31, 2016 18.36M
December 31, 2015 16.46M
September 30, 2015 13.63M
June 30, 2015 9.991M
March 31, 2015 6.086M
December 31, 2014 2.870M
September 30, 2014 1.084M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Palatin Technologies, Inc. 9.402M
Unicycive Therapeutics, Inc. 23.53M
Nuvectis Pharma, Inc. 9.218M
ACADIA Pharmaceuticals, Inc. 620.29M
Alnylam Pharmaceuticals, Inc. 1.318B